|
Volumn 159, Issue 4, 2008, Pages 895-902
|
Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis
|
Author keywords
Cardiovascular disease; Epidemiology; Myocardial infarction; Psoriasis; Risk factors
|
Indexed keywords
ADAPALENE;
AZATHIOPRINE;
BUDESONIDE;
BUSULFAN;
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
EPIRUBICIN;
ESTRAMUSTINE;
ETANERCEPT;
ETOPOSIDE;
ETRETINATE;
FLUOROURACIL;
FLUTICASONE;
HYDROXYUREA;
INFLIXIMAB;
ISOTRETINOIN;
LEFLUNOMIDE;
MELPHALAN;
MERCAPTOPURINE;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PACLITAXEL;
PIMECROLIMUS;
PREDNISOLONE;
RAPAMYCIN;
RETINOIC ACID;
TACROLIMUS;
THALIDOMIDE;
UNINDEXED DRUG;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CARDIOVASCULAR RISK;
CONTROLLED STUDY;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
FEMALE;
HEART INFARCTION;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
OBESITY;
PREVALENCE;
PRIORITY JOURNAL;
PSORIASIS;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
BOSTON;
CARDIOVASCULAR DISEASES;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
INFANT;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PROPORTIONAL HAZARDS MODELS;
PSORIASIS;
RISK FACTORS;
|
EID: 51849159602
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/j.1365-2133.2008.08707.x Document Type: Article |
Times cited : (223)
|
References (5)
|